MERS-CoV vaccine is safe and induces strong immunity in Army-led first-in-human trial
A Middle East respiratory syndrome coronavirus (MERS CoV) vaccine candidate was shown to be safe, well-tolerated, and induced a robust immune response in a Phase 1 first-in-human clinical trial. Initial findings from the ...
Jul 25, 2019
0
3